245 related articles for article (PubMed ID: 9513607)
1. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma.
Tubach F; Hayem G; Elias A; Nicaise P; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1997 Jun; 64(6):362-7. PubMed ID: 9513607
[TBL] [Abstract][Full Text] [Related]
2. [The clinical spectrum of patients with anticentromere antibodies].
Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome with anticentromere antibodies.
Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
[TBL] [Abstract][Full Text] [Related]
5. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
[No Abstract] [Full Text] [Related]
6. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
7. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
8. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
9. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
10. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
12. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
Fritzler MJ; Kinsella TD
Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
[TBL] [Abstract][Full Text] [Related]
13. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
14. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
[TBL] [Abstract][Full Text] [Related]
15. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
16. Anticentromere antibody--clinical associations. A study of 44 patients.
Caramaschi P; Biasi D; Manzo T; Carletto A; Poli F; Bambara LM
Rheumatol Int; 1995; 14(6):253-5. PubMed ID: 7597381
[TBL] [Abstract][Full Text] [Related]
17. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
[TBL] [Abstract][Full Text] [Related]
19. [The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions].
Sato S; Takehara K; Ishibashi Y
Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):97-104. PubMed ID: 2072581
[TBL] [Abstract][Full Text] [Related]
20. [Anti-centromere antibodies. Study of 67 positive sera].
Renier G; Le Normand I; Chevailler A; Verret JL; Renier JC; Hurez D
Rev Med Interne; 1992 Nov; 13(6):413-4, 417-8. PubMed ID: 1344922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
